1 / 15

Review Article Neurogenic pulmonary edema

Review Article Neurogenic pulmonary edema. Acta Anaesthesiol Scand 2007; 51: 447-445 R4 이동현. Neurogenic pulmonary edema(NPE) Defined as acute pulmonary edema occurring shortly after a central neurologic insult

dacey
Télécharger la présentation

Review Article Neurogenic pulmonary edema

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Review ArticleNeurogenic pulmonary edema ActaAnaesthesiol Scand 2007; 51: 447-445 R4 이동현

  2. Neurogenic pulmonary edema(NPE) • Defined as acute pulmonary edema occurring shortly after a central neurologic insult • Often present without pre-existing cardiovascular or pulmonary pathology that could explain the edema • But, dose not exclude a coexisting effect of neurologic insult on myocardial function • Cause of confusion in reported incidence of NPE

  3. Epidemiology • Cases reported in • Subarachnoid hemorrhage(SAH) • Traumatic brain injuries • Cervical medulla injuries • Cerebral thrombosis • Cerebral gas embolism • Intracerebral hemorrhage • Intracranial tumors • Epilepsy • Postoperative intracranial surgery • Enterovirus encephalitis(hand, foot, mouse disease) • Meningitis • Multiple sclesosis • Brambrink and Dick • Cerebral hemorrhage(71%), seizure activity(2%), cerebral trauma(1%)

  4. Epidemiology • SAH • Main cause of NPE • Pulmonary edema after SAH : 23% • Friedman et al : NPE in 2% of 305 SAH pts • Between D1 and D7 after SAH • Most important risk factors • Clinical and radiological severity of SAH • Vertebral artery origin • Positive correlation • Age • Delay to surgery • Intentional hypervolemia • Early detection and treatment of NPE minimize mortality associated with SAH.

  5. Epidemiology • Head injury • Up to 20% of severe head injury • In autopsy database • Incidence of NPE : 32% • 50% in victims dying within 96 hrs. • Status epilepticus • 1/3 of status epilepticus patients • Major cause of NPE in children • Occurs mainly during post-ictal period • Can be recurrent

  6. Pathophysiology • Hemodynamic mechanism • Adrenergic response to cerebral insult • Intense pulmonary vasoconstriction • Increase in pulmonary hydrostatic pressure • Increase in permeability of pulmonary capillaries • Inflammatory mechanism • Also induce an increase in permeability of pulmonary capillaries • NPE trigger zones • Hypothalamus • Medulla oblongata

  7. Pathophysiology • Hemodynamic mechanism • Sudden increase in ICP induce • α-adrenergic response • Increase in pulmonary and systemic vasoconstriction • Subsequent fluid shift into pulmonary alveoli and and interstitial space • Pulmonary vasoconstriction increase cardiac workload • Severe myocardial depression • Even stunned myocardium • Cf) patients with hypertensive cardiomyopathy • Less sensitive to catecholamine • Some protection against this acute effect

  8. Pathophysiology • Norepinephrine and neuropeptide Y • Located in sympathetic nerve ending • Play important role in NPE • Vasoconstrictive action • Increasing pulmonary vascular permeability • Endothelin-1 • One of the most potent vasoconstrictor • Time dependent increase in rats with NPE • Intrathecal injection in rats 22-fold increase in pulmonary vascular permeability • Activation of medullaryendothelin receptors • Stimulate norepinephrine release • Nitric oxide • Endothelial-mediated vasodilatation • In rats with cerebral trauma, injection of nitric oxide synthase inhibitor increase mortality

  9. Pathophysiology • Inflammatory mechanism • Cerebral insult cause local inflammatory reaction • Brain cytokines and chemokines • Produced by astrocytes and microglial cell • TNF-α, IL-1β, IL-6 • Diffuse into systemic circulation after BBB disruption • Cause peripheral organ inflammation • Cause expression of substance P, neurokinin A • Bronchoconstriction • Edema of bronchial mucosa • Increase of pulmonary capillary permeability • Increase leukocyte activation

  10. Diagnosis • Clinical presentation • No specific clinical presentation • Signs of acute pulmonary edema • Usually lack of signs of LV failure • Tachypnea, tachycardia, basal pulmonary crackles, respiratory failure and lack of cardiac gallop • Unilateral NPE seems to be possible • Complementary investigations • CXR : bilateral pulmonary infiltrates • Echocardiogram, TE Doppler, CVP : normal • ECG : unchanged • No specific biologic marker • Troponin Ic, brain natriuretic peptide(BNP) elevation • Blood C-reactive protein, IL-6 level can be increased

  11. Differential diagnosis • Aspiration pneumonia and ventilator-associated pneumonia • Complications associated with impairment of consciousness • Blood level of pro-calcitonin : evidence of invasive bacterial infection • Ventilation-induced lung injury • Decreased tolerance to alveolar stretching • Over-inflation injury • Increased susceptibility to reperfusion injury

  12. Treatment/management • May resolve in 48-72 h with appropriate Mx • Prognosis is dependent on neurologic injury. • Acute neurologic insult • Control of triggering CNS insult • Decrease ICP, evacuate hematoma, treat convulsion • Classical pulmonary edema therapy • Ventilation • Patients with serious NPE : must be intubated early, sedated and ventilated with PEEP • PEEP < 15 cmH2O : not impede cerebral perfusion pr. • Permissive hypercapnia and prone position • Direct tracheal insufflation • Nitric oxide inhalation

  13. Treatment/management • Hemodynamic function • Reduce preload and afterload • Increase myocardial contractility • Hypotensive agent without cerebral vasodilatory effects : urapidil, clonidine • Dobutamine • Epinephrine and norepinephrine • Diuretics • Neurologic care • Decreasing high ICP • Optimizing cerebral perfusion pressure • Mannitol or hypertonic saline

  14. Treatment/management • Brain death • Permissive hypercapnia, nitric oxide inhalation • Optimize V/Q ratio • Decrease pulmonary vascular pressure • Vasoactive drugs • Maintain peripheral organ hypoperfusion • Prevent multiorgan failure

  15. Conclusion • NPE should be considered when patients with central neurologic injury suddenly become dyspneic or present with decreased PaO2/FiO2 ratio. • Associated mortality is high. • Recovery is usually rapid with appropriate management. • Early treatment of underlying neurologic cause is cornerstone of NPE Mx. • Most patients should be intubated, sedated, ventilated with PEEP and maintained with normal hemodynamic stability. • NPE in brain death is major cause of graft dysfunction and even of transplantation failure.

More Related